BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Net Current Assets History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Current Assets (Including Current Investments) | ₹188 Cr | ₹156 Cr | ₹140 Cr | ₹78 Cr | ₹59 Cr |
What is the latest Net Current Assets ratio of BALAXI PHARMACEUTICALS ?
| Year | Net Current Assets |
|---|---|
| Mar2025 | ₹188 Cr |
| Mar2024 | ₹156 Cr |
| Mar2023 | ₹140 Cr |
| Mar2022 | ₹78 Cr |
| Mar2021 | ₹59 Cr |
How is Net Current Assets of BALAXI PHARMACEUTICALS Trending?
| Years | Net Current Assets | % Change | |
|---|---|---|---|
| Mar2025 | ₹188 Cr | 20.68 | |
| Mar2024 | ₹156 Cr | 11.11 | |
| Mar2023 | ₹140 Cr | 80.59 | |
| Mar2022 | ₹78 Cr | 31.58 | |
| Mar2021 | ₹59 Cr | - | |
Compare Net Current Assets of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹120.6 Cr | -4.9% | -15.5% | -68.4% | Stock Analytics | |
| ADANI ENTERPRISES | ₹276,809.0 Cr | -4.8% | -0.6% | -2.5% | Stock Analytics | |
| REDINGTON | ₹20,568.5 Cr | -3.2% | -3.8% | 14.4% | Stock Analytics | |
| HONASA CONSUMER | ₹9,809.9 Cr | 2.6% | 4.7% | 39.6% | Stock Analytics | |
| MMTC | ₹9,583.5 Cr | -3.3% | -11% | -1.8% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹8,443.4 Cr | -5.6% | -6.6% | 22.4% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -4.9% |
-15.5% |
-68.4% |
| SENSEX | -1.1% |
-1.2% |
5.9% |
You may also like the below Video Courses